Prof. Dr. Markus Neurath

Lehrstuhl für Innere Medizin I (Medizin 1)

Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis (2020) Lechner KS, Neurath M, Weigmann B Journal article, Review article Physical activity and advanced cancer: evidence of exercise-sensitive genes regulating prostate cancer cell proliferation and apoptosis (2020) Schwappacher R, Schink K, Sologub S, Dieterich W, Reljic D, Friedrich O, Herrmann HJ, et al. Journal article Ultrasound-Based Attenuation Imaging for the Non-Invasive Quantification of Liver Fat-A Pilot Study on Feasibility and Inter-Observer Variability (2020) Jesper D, Klett D, Schellhaas B, Pfeifer L, Leppkes M, Waldner M, Neurath M, Strobel D Journal article IL-36 in chronic inflammation and cancer (2020) Neurath M Journal article, Review article How Much Liver Tissue Is Required for Sufficient Histological Staging in Patients with Primary Biliary Cholangitis? (2020) Vetter M, Kremer A, Agaimy A, Pfeifer L, Neurath M, Zopf S, Siebler J Journal article Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes? (2020) Abdullah A, Neurath M, Atreya R Journal article Covid-19 and immunomodulation in IBD (2020) Neurath M Journal article, Review article COVID-19: risk for cytokine targeting in chronic inflammatory diseases? (2020) Schett G, Sticherling M, Neurath M Journal article An IFN-STAT1-MLKL axis drives programmed necrosis of Paneth cells in Crohn's ileitis (2020) Hartmann L, Siegmund B, Weidinger C, Becker C, Neurath M, Günther C Conference contribution Efficacy, safety, and pharmacokinetics after switching from infliximab originator to biosimilar SB2 in inflammatory bowel disease patients: A long-term observational, prospective cohort study (2020) Fischer S, Mesfin SE, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Conference contribution